Friday's top analyst upgrades and downgrades included ADS, BioMarin Pharmaceutical, Dick's Sporting Goods, Freeport-McMoRan, Northrop Grumman, Simon Properties and U.S. Steel.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including Alexion Pharma, Activision Blizzard, Baker Hughes, BioMarin, and more.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including Anthem, BioMarin, CRISPR, GE and more.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including BioCryst, Editas, Groupon, Sunrun, Twitter and more.
In a move that investors looking for more defensive ideas should applaud, the analysts at Goldman Sachs have added Bristol-Myers Squibb to the Americas Conviction List. Plus, here are four additional health…
Earnings season is upon us and investors are pining for information about which stocks and sectors will do well. After all, many investors missed the bulk of the recovery from March’s panic…
Thursday's top analyst upgrades and downgrades included BioMarin Pharmaceuticals, Checkpoint Software Technologies, Cinemark, Fortinet, Palo Alto Networks, Regeneron Pharmaceuticals, Shake Shack, Ventas and Zscaler.
BioMarin Pharmaceutical stock was crushed on Wednesday after an FDA response regarding its valoctocogene roxaparvovec gene therapy for severe hemophilia A.
Chris Lange Goldman Sachs has seven biopharma stocks on its Conviction Buy list, and these are not all coronavirus plays. The firm thinks these stocks could go on the offensive for the rest of…
Wednesday's top analyst upgrades and downgrades Apple, Boeing, Chevron, Chewy, Cisco Systems, Cree, eBay, Etsy, GameStop, Groupon, Micron Technology, United Airlines and Yext.
These five high-conviction health care picks make sense for accounts looking to gain exposure to a sector that should continue to do well the rest of 2020 and for years to come,…
With the potential for continued economic and political volatility, now is probably a good time for a little spring cleaning to portfolios. Here are six new additions to the Jefferies Franchise Picks…
These are five of the best stocks in a sector that has been humming along in what has been a turbulent year. They are all included on the Goldman Sachs Conviction List…
Goldman Sachs analysts are bullish on these four top biotech stocks in front of first-quarter results. None of these companies is a proverbial one-trick pony, and they all are potential takeover candidates.
Tuesday's top analyst calls included Advanced Micro Devices, Alcoa, Biomarin Pharmaceutical, Coca-Cola, Ford, General Motors, Intel, Kinder Morgan, Micron Technology, Nvidia, Tesla, Twitter and Zillow.
